DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 58 filers reported holding OBALON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$1,531,000
-48.1%
446,2840.0%0.05%
-54.3%
Q4 2017$2,950,000
-11.9%
446,284
+27.0%
0.12%
-23.2%
Q3 2017$3,348,000
+84.6%
351,284
+91.9%
0.15%
+55.7%
Q2 2017$1,814,000
+709.8%
183,086
+773.8%
0.10%
+977.8%
Q1 2017$224,00020,9530.01%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$24,313,0005.76%
Tamarack Advisers, LP 528,066$5,233,0003.06%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$3,274,0000.50%
FORMULA GROWTH LTD 108,998$1,080,0000.19%
Moisand Fitzgerald Tamayo, LLC 6,842$268,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 183,086$1,814,0000.10%
KORNITZER CAPITAL MANAGEMENT INC /KS 422,410$4,186,0000.07%
TIVERTON ASSET MANAGEMENT LLC 130,050$1,289,0000.07%
Bellevue Group AG 45,000$446,0000.05%
Laird Norton Wetherby Wealth Management, LLC 24,038$238,0000.04%
View complete list of OBALON THERAPEUTICS INC shareholders